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BACKGROUND: We aimed to identify global blood and retinal gene expression patterns in murine oxygen-induced retinopathy
(OIR), a common model of retinopathy of prematurity, which may allow better understanding of the pathogenesis of this severe
ocular prematurity complication and identification of potential blood biomarkers.
METHODS: A total of 120 C57BL/6J mice were randomly divided into an OIR group, in which 7-day-old pups were maintained in
75% oxygen for 5 days, or a control group. RNA was extracted from the whole-blood mononuclear cells and retinal cells on days 12,
17, and 28. Gene expression in the RNA samples was evaluated with mouse gene expression microarrays.
RESULTS: There were 38, 1370 and 111 genes, the expression of which differed between the OIR and control retinas on days 12, 17,
and 28, respectively. Gene expression in the blood mononuclear cells was significantly altered only on day 17. Deptor and Nol4
genes showed reduced expression both in the blood and retinal cells on day 17.
CONCLUSION: There are sustained marked changes in the global pattern of gene expression in the OIR mice retinas. An altered
expression of Deptor and Nol4 genes in the blood mononuclear cells requires further investigation as they may indicate retinal
neovascularization.
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INTRODUCTION
Retinopathy of prematurity (ROP), a proliferative retinal vascular
disorder affecting premature infants, is currently a major cause of
potentially preventable blindness in children.1 It is estimated that
ROP affects 33.2% of neonates with birth weight < 1500 g.2 ROP
develops in two phases; phase 1 is initiated by hyperoxia and
exacerbated by lack of the essential factors provided in utero,
followed by a destruction of existing vessels and arrest of normal
vessel development. Phase 2 is driven by increased metabolic
activity of the hypoxic retina, which leads to both revascularization
and pathological neovascularization.3 An excessive abnormal
compensatory vessel growth may result in fibrous scar develop-
ment, and ultimately leads to retinal detachment.4 We believe that
better understanding of the pathomechanisms behind ROP
coupled with an early and effective method of the risk
stratification of ROP development would allow to take true
preventive actions and/or targeted treatment. Genome-wide
microarray analysis provides a simultaneous examination of the
expression of thousands of genes in a single experiment to create
a comprehensive picture of dysregulated genes and pathways. A
possibility to use the animal model that mimics key features of the
disease provides invaluable tool for studying ROP underlying
mechanisms not only in the blood, but also in the target tissue
such as retina. The most widely used model is a murine model of
oxygen-induced retinopathy (OIR).5 In mice, the retinas are mostly
avascular after birth, and retinal vascularization occurs in the early
neonatal period, resembling situation observed in the prematurely
born infants. 5-day long continuous exposure to high oxygen
levels imitates the biphasic retinal vascular response observed in
the young infants with ROP.6 Up till now, exploration of the retinal
gene expression pattern in the murine OIR model was assessed
partially. Sato et al.7 evaluated only a selected set of genes related
to angiogenesis and inflammation. Subsequent studies investi-
gated expression of the entire genome, but at the selected time
points—Ishikawa et al.8 and Yang et al.9 determined a profile of
gene expression in murine retinas soon after end of hyperoxia,
whereas Recchia et al.10 additionally verified gene expression in
rodent retinas during neovascularization phase. The goal of this
study was to identify potential ROP blood biomarkers and provide
a more molecular-based understanding of ROP by comparing the
gene expression profile at three time points (vaso-obliteration
(P12), maximal neovascularization (P17) and during normalization
of the retinal damage (P28)) in the blood mononuclear cells and
retinas obtained from the mice with and without OIR. We
hypothesized that supplemental oxygen as compared with air
induced gene expression changes in the blood and retinal cells,
which varied depending on the length of time following exposure
to hyperoxia.
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Murine model of OIR
The Norwegian Animal Research Authority approved all experi-
ment protocols. The animals were cared for and handled in
accordance with the Norwegian Legislation and Directive. OIR was
induced in C57BL/6 mice (received from: Jackson Laboratories, Bar
Harbor, ME) according to the protocol described by Smith et al.6
Briefly, mice were housed and bred at 24 °C at a 12:12 light/dark
cycle with access to a standard rodent pellets and water ad
libitum. On the postnatal day 7 (P7), all pups within each litter
were earmarked with use of surgical micro-scissors. When a pup
was picked up from the cage, it received a number drawn by an
assistant from blinded tickets containing numbers from 1 to 8. The
procedure was repeated until every pup had its own number
within the litter. The smallest pups (according to their body weight
on P7) out of litters of >8, or any abnormal pups (with visible
morphologic abnormalities) were excluded from the experiment.
Each litter with a nursing mother was then randomized either to
hyperoxia (75% oxygen) or normoxia (21% oxygen) conditions
(also by drawing a ticket either with a symbol N for normoxia or H
for hyperoxia), then transferred in their cage into A-Chambers
(BioSpherix Ltd, Parish, NY), where they were kept until day 12
(P12). Seventy-five percent oxygen concentration was achieved
with a conventional oxygen mixer (oxygen (AGA AS, Oslo, Norway)
plus room air). Each chamber was continuously monitored for
oxygen concentration (O2-monitor, ProOX110 BioSpherix Ltd,
Parish, NY), temperature and humidity (Thermometer/Hygrometer
Clas Ohlson, Insjon, Sweden), and CO2 level (ProCO2 P120,
BioSpherix Ltd, Parish, NY). An open water source kept air
humidity at 40–50%. Every day there was a 10–20min break in
oxygen supply for airing the chamber and checking the mice.
Nursing dams stayed with their own litters throughout the entire
experiment. The cages containing pups with their mothers were
removed from the hyperoxia/normoxia chambers on day P12.
Before removing cages with mice from A-Chambers, one more
randomization was performed; namely tickets with symbols,
indicating the predicted harvesting day and type of analyses
were prepared, then they were randomly assigned to each pup
from either hyperoxia or normoxia group. 1/3 of the pups were
immediately anesthetized (zolazepam/tiletamine/xylazine/fenta-
nyl standard ZRF cocktail, 0.1 ml/10 g intraperitoneally), their
gender was assessed, and the blood samples obtained by cardiac
puncture were collected to 1ml syringes (Terumo U40/1 ml,
needle 0.33 x 12), flushed with EDTA, then processed within 1 h, as
described below. Then mice were killed by aorta cut and their eyes
were enucleated. The rest of the litters with nursing mothers
returned to room air and stayed under normal conditions till P17,
or P28, according to their randomly selected groups. Their blood
and retinas were collected and processed the same way as
described above.
Murine blood mononuclear cells purification and total RNA
isolation
Blood sample was diluted with equal amount of sterile phosphate-
buffered saline (PBS) solution (GE Healthcare Life Sciences). One
milliliter of Ficoll-Paque (GE Healthcare Life Sciences) was inserted
into a 2ml Eppendorf centrifuge tube. Diluted blood sample was
layered carefully onto the Ficoll-Paque. Then sample was
centrifuged at 400 gav for 30min at 18 °C. After removing an
upper layer, a lymphocyte layer was transferred into a new 2ml
Eppendorf tube, filled with PBS solution, mixed and afresh
centrifuged at 100 gav for 10 min at 18 °C. Then the supernatant
was discarded carefully not to disrupt the pellet of the peripheral
blood mononuclear cells (PBMC). Subsequently, PBMCs were
washed again with PBS solution (centrifugation repeated under
the same conditions). Afterwards 800 µl of lysis solution and 50 µl
of sodium acetate (Mouse RiboPure™-Blood RNA Isolation Kit;
Invitrogen; Thermo Fisher Scientific) was added, the cells were
suspended by manual pipetting, then the samples were placed
immediately at −80 °C. Total RNA was isolated with the use of
Mouse RiboPure™-Blood RNA Isolation Kit (Invitrogen; Thermo
Fisher Scientific) according to the manufacturer’s instructions. RNA
concentration was measured with the use of NanoDrop Spectro-
photometer (NanoDrop ND-1000; Thermoscientific, Waltham), and
RNA quality was determined by TapeStation 4200 (Agilent, Santa
Clara).
Obtaining retinas and total RNA isolation
Whole retinas free of additional tissues were isolated immedi-
ately under a dissecting microscope, and put into vials with
RNAlater® Stabilization Solution (Thermo Fisher Scientific), kept
for 24 h in+ 4 °C and stored in a −80 °C freezer until further use.
To isolate sufficient total RNA for microarray analysis, two retinas
from the same mouse were pooled. Retina tissues were then
disrupted with the use of TissueRuptor handheld rotor-stator
homogenizer (Qiagen, Hilden, Germany) and total RNA from the
retina cells was processed by RNeasy Micro Kit (Qiagen, Hilden,
Germany) as described by the manufacturer. RNA concentration
was measured with the use of NanoDrop Spectrophotometer
(NanoDrop ND-1000; Thermoscientific, Waltham), and RNA
quality was determined by TapeStation 4200 (Agilent, Santa
Clara).
Validation of the model
Eyes from randomly selected 36 pups both from normoxia and
hyperoxia groups, 1/3 from each harvesting time point, were used
for the verification of the model, according to the methods
described in details elsewhere.3 Briefly, the eye was enucleated
and fixed with 4% Paraformaldehyde Solution (Boster Biological
Technology, Pleasanton CA). Then under the dissecting micro-
scope the retina was isolated, incubated in 0.5% Triton X-100
(Sigma, St. Louis, MO) and stained in the lectin solution with Alexa
Fluor 594–I21413, Molecular Probes. Then under a dissecting
microscope retinas were mounted on a microscope slide and
cover slipped with SlowFade medium (Thermo Fisher Scientific,
Waltham, MA). Images were obtained using the Zeiss AxioCam
MRc, Zeiss AxioObserver.Z1 microscope and AxioVision 4.8 soft-
ware. Using Adobe Photoshop CS6, the percentage of avascular
retina, as well as neovascularization fraction was calculated by an
independent researcher.
Microarray analyses
One-hundred nanograms of total RNA was used for each single
experiment with use of SurePrint G3 Mouse Gene Expression
8x60K Microarrays (Agilent, Santa Clara) to study the mRNA
expression. Microarray gene expression experiment was per-
formed according to the manufacturer’s protocol (Two-Color
Microarray-Based Gene Expression Analysis—Low Input Quick
Amp Labeling ver.6.5). The universal mouse reference RNA
(Agilent Technologies, CA) was used as an internal control. After
experiment, the microarrays were scanned by SureScan Microarray
Scanner (Agilent, Santa Clara) and data was extracted using
Feature Extraction Software (Agilent, Santa Clara). Details of the
microarray experiment are available on-line (https://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE130400, https://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130347)
Quantitative real-time PCR (qRT-PCR) verification of gene
expression
To verify the microarray gene expression data, ten genes were
randomly selected for a method validation using qRT-PCR.
The genes represented well described and characterized murine
genes chosen from the popular databases, such as Ensembl,
NCBI, or DAVID. The genes specific for retinas included: Cidea,
Etnppi, Spink13, Gabrb1, Bfsf2, Tnnt2, Adm, Gfap, Nupr, Actg2.
The primers and probes were commercially available (Thermo
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Fischer Scientific, USA). The complementary DNA was synthe-
sized using SuperScript III kit (Thermo Fischer Scientific)
according to the manufacturer’s protocol. The qRT-PCR analysis
was performed using Applied Biosystems 7500 Real-Time PCR
System and TaqMan Universal Master Mix II, no UNG (Thermo
Fischer Scientific). The qRT-PCR reactions were performed in 96-
well plates at 95 °C for 10 min, followed by 40 cycles of 95 °C for
15 s and 62 °C for 1 min. All samples were run in duplicates.
Gene expression was calculated by ΔΔCt method, normalized
against the endogenous control gene Gapdh and for each gene
fold change (FC) values were calculated as previously
described.11 In blood samples, the same validation method as
described above was performed in seven randomly selected
genes, due to very limited amount of blood and RNA obtained
from the small pups.
Statistical analysis
Gender distribution was evaluated with chi-square test. A
probability value of < 0.05 was considered statistically significant.
JMP® 13.1.0 (SAS Institute Inc., 2016) was used for statistical
analysis.
Microarray data were analyzed by GeneSpring GX software
(Agilent, Santa Clara). Raw microarray data were normalized, then
moderated t-test was applied to compare gene expression
between the study groups. The results were corrected for multiple
testing by the Benjamini–Hochberg procedure. A 0.05 significance
level of the adjusted p-values was used. The genes, the expression
of which was significantly altered during the experiment, were
further investigated using established databases, such as Gene
Cards (http://www.genecards.org), Mouse genome informatics
(http://www.informatics.jax.org), and NCBI gene (http://www.ncbi.
nlm.nih.gov), Ensembl (http://www.ensembl.org/Mus_musculus).
RESULTS
Animal model of OIR
On P7, 120 C57BL/6J mice underwent the experiment—60 were
randomly assigned to the OIR group, and the other 60 formed the
control group. All animals survived the experiment, and were
further randomized according to the day of tissue harvesting (P12,
P17, or P28). Six mice from each group from every experimental
time point were used for model verification. Out of 84 animals
assigned to the gene expression analysis, five were excluded due
to insufficient RNA concentration and low sample quality (Fig. 1).
The two groups did not differ in gender distribution (Table 1).
There were no significant weight differences between the groups
when entering experiment (P7); however, OIR group revealed
transient significant extrauterine growth retardation on P12, which
normalized after day P17 (Table 2). Retinal vascular staining
confirmed oxygen-related damage of the retinas in the OIR group
(Fig. 2).
Overall gene expression changes in retina
Microarray analysis revealed significant differences between OIR
and control group in gene expression in murine retinas in all
experimental time points (Table 3 and Fig. 3—part 1). Overall,
there were 39 genes (38 genes with annotated gene symbol)
differentially expressed on day P12, 1478 genes (1370 genes with
annotated gene symbol) on P17, and 114 genes (111 genes with
annotated gene symbol) on P28. On P12, the predominant
fraction of the significantly altered genes showed reduced
expression, whereas the majority of the genes demonstrated
increased expression in later days, both P17 and P28, in the OIR
group when compared with the controls. We observed a shift in
gene expression pattern in OIR murine retinas, starting from a
significantly diminished gene expression immediately after
Postnatal day 12
Postnatal day 17
Harvested for blood/retinas samples (n = 14)
Included into gene analyses = 13
Excluded from analyses = 1
Model verification (n = 6)
Harvested for blood/retinas samples (n = 14)
Included into gene analyses = 13
Excluded from analyses = 1
Model verification (n = 6)
Postnatal day 28
Harvested for blood/retinas samples (n = 14)
Included into gene analyses = 13
Excluded from analyses = 1
Model verification (n = 6)
Postnatal day 12
Postnatal day 17
Harvested for blood/retinas samples (n = 14)
Included into gene analyses = 13
Excluded from analyses = 1
Model verification (n = 6)
Harvested for blood/retinas samples (n = 14)
Included into gene analyses = 13
Excluded from analyses = 1
Model verification (n = 6)
Postnatal day 28
Harvested for blood/retinas samples (n = 14)
Included into gene analyses = 14
Excluded from analyses = 0
Model verification (n = 6)
C57BL/6J mice (n = 120)
Postnatal day 7
Hyperoxia
FiO2* 0.75, 5 days
(n = 60)
Normoxia
FiO2* 0.21, 5 days
(n = 60)
Fig. 1 Flowchart of the study. Experimental design and experimental groups. *FiO2—fraction of inspired oxygen
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hyperoxia exposure through a peak gene overexpression on P17,
when maximal neovascularization was observed, till gradual
decline of gene overexpression on P28 (Fig. 3).
The genes with the most diverse expression defined by the
highest fold change (FC) values are listed in Tables 4 and 5.
Overall gene expression changes in blood
There were significant differences in gene expression only on P17
in OIR mice in comparison to the control animals in the PBMC
analysis (Fig. 3). Out of 63 genes (49 genes with known official
Gene symbols), around two-thirds were significantly upregulated,
whereas one-third was downregulated (Table 3 and Fig. 3—part
2). Two genes, Deptor and Nol4 showed decreased expression
both in the blood and retinal tissues on day P17 (FCretina <−3;
FCblood <−2).
Quantitative real-time PCR
The validation procedure performed for genes randomly selected
before experiments did not reveal significant differences between
the results obtained with use of microarrays as compared with
real-time PCR method (t-test p-values for each time point > 0.05).
Detailed results for blood and retina tissue are shown in Fig. 4.
DISCUSSION
The goal of the study was to identify short- and long-term
molecular alterations in the blood and retina after exposure to
high levels of inhaled oxygen using a well-characterized murine
model of oxygen-induced retinopathy. The nature of the study
was mainly exploratory.
On P12, the genes with the most decreased expression were
those associated with angiogenesis (Ccm2l, Mmrn2, Ets1, Ptprb,
CD34, Robo4), cell shape rearrangement (Arap3), ion channel
formation (Abcc9), as well as receptors involved in cell-to-cell
interactions (Adgre5). Interestingly, some of the genes regulating
angiogenesis were first underexpressed on P12, then they were
overexpressed on P17 to finally normalize their expression on P28.
An example of such gene response, the expression of which
reversed between P12 and P17, was Cd34 gene. Cd34 encodes a
sialomucin CD34, ubiquitously expressed in the luminal mem-
brane of the endothelial cells, which promotes angiogenesis.12
CD34 transcript and protein levels are increased during human
angiogenesis.13 According to Siemerink et al.13 its expression
promotes pathological neovascularization in a murine OIR model
by enhancing epi-retinal tuft formation.
On P17, the most profound decrease in expression was
observed in the genes associated with: apoptosis (Cidea),
metabolism (Etnppl), cell division (Spc25), ion channels (Kcne1l,
Kcnd2, Gabrb1, Scn11a), and receptor components (Garb1, Tacr3,
Gpr101), as well as serine protease inhibitors (Spink13).
On the same day, P17, the top overexpressed genes were Esm1
and Edn2 genes. Esm1 encodes endothelial cell-specific molecule 1
(Esm1). Animal model showed that Esm1, in cooperation with
vascular endothelial growth factor (VEGF), plays an important role
in both physiologic and pathological angiogenesis and vascular
Table 2. Mean weight in selected time points in OIR and control
animals, whose tissues were further proceeded for the transcriptome
analysis
OIR group Normoxia group p (two sided t-test)
Weight on postnatal day (P) [g]:
P7 (mean, (SD)) 4.13 (0.41) 3.98 (0.59) 0.2092
P10 (mean, (SD)) 5.31 (0.54) 5.29 (0.53) 0.8675
P12 (mean, (SD)) 5.58 (0.54) 6.06 (0.56) 0.0003
P14 (mean, (SD)) 6.13 (0.68) 6.92 (0.80) 0.0004
P17 (mean, (SD)) 7.03 (0.78) 7.53 (0.84) 0.0268
P21 (mean, (SD)) 8.49 (1.19) 8.86 (1.02) 0.3939






Fig. 2 Retinal flat mounts from OIR groups at different time points:
P12H (postnatal day 12, right after hyperoxia), P17H (postnatal day
17, 5 days after hyperoxia), P28H (postnatal day 28, 16 days after
hyperoxia). The retinal vessels were stained with lectin. P12H: a vaso-
obliteration showed as a large avascular zone in the central retina, b
the avascular area presented in white; P17H: c maximal pathological
retinal neovascularization (NV). The retinal vessels were dilated and
there were tufts of NV on the surface of the retina, d the avascular
area shown in white, e the areas of neovascularization shown in
white; P28H: f neovascular changes regression, g the remained areas
of neovascularization are shown in white
Table 1. Characteristics of dams and litters in the study groups
Hyperoxia Normoxia Pearson chi-square p—
for gender distribution
No of dams/litters (n) Male pups (n) Female pups (n) No of dams/litters (n) Male pups (n) Female pups (n)
In total 18 20 19 16 21 19 0.5400
P12 12 5 8 12 8 5 0.2393
P17 10 10 3 10 7 6 0.2162
P28 10 5 8 9 6 8 0.8163
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permeability. It is also involved in some inflammatory processes by
regulation of leukocytes extravasation.14
Edn2 gene, which showed 18.6-fold increased expression on
P17, encodes endothelin (ET) 2, a potent vasoconstrictor that
contributes to regulation of the retinal blood flow, and may exert
mitogenic, pro-oxidative, and proinflammatory effects.15 Our
results of Edn2 overexpression confirmed previously published
findings of increased abundance of Edn2 transcripts in various
retinal injuries.16 A pharmacological blockade of the ET system
prevented pathological neovascularization in a murine model of
OIR.17 Other genes that showed increased expression in our study
were also evaluated elsewhere. Inhibition of adrenomedullin, a
peptide involved in vasodilation, angiogenesis and vascular
leakage, encoded by Adm gene, highly overexpressed in our
study, was identified as a potential target of new therapies in
diabetic retinopathy.18 On the other hand, an increased expres-
sion of Gfap gene might indicate reactive gliosis as a reaction to
retinal impairment.19
In previous studies, murine retinal neovascularization as
visualized in the tissue samples spontaneously regressed between
P17 and P25.3 However, our results indicated that despite almost
complete disappearance of the visible neovascular changes, the
alterations in gene expression in the retinal cells remained. In our
study, we also examined gene expression in the retinas from mice
on P28, which in mouse terms was considered a "young" adult or
in human terms, at least an adolescent. We observed sustained
overexpression of the several important genes (Apln, Pcolce,
Cebpd, Bcl3, Tnnt2, C4b) from P17 to P28. Apln gene encodes a
peptide apelin that stimulated angiogenesis and induces retinal
neovascularization in the VEGF-independent manner.20 It was
hypothesized, that apelin, after binding to its APJ receptor,
promotes nitric oxide production through PI3K⁄Akt signaling and
nitric oxide synthase activation.21 Apelin production increases in
response to hypoxia and transcription enhancement by hypoxia-
inducible factor-1.22 Of note, apelin was also found in vitreous
humor of the patients with diabetic retinopathy.23 Interestingly,
Table 3. Summary of the number of differentially expressed genes in retina tissue and blood between OIR and control group at different time points
(cutoff: moderated t-test corrected p-value < 0.05)
No of differentially expressed genes with annotated gene symbol
(no of differentially expressed microarray probes)
P12 P17 P28
Retina Blood Retina Blood Retina Blood
All 38 (39) 0 (0) 1370 (1478) 49 (63) 111 (114) 0 (0)
Overexpressed genes 1 0 855 34 (38) 107 0
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Fig. 3 Volcano plots demonstrating that OIR was associated with alterations of specific genes in all analyzed time points (a—P12, b —P17,
c—P28). I—gene expression changes in retina, II—gene expression changes in blood. The vertical axis value—negative log of the p-values.
The horizontal axis—log2 change (FC—fold change) between the two experimental conditions (OIR vs. normoxia). The red dots represent
genes, whose expression was significantly changed between the study vs. control groups (corrected p-value < 0.05)
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apelin knockout mice treated with VEGF showed impaired
angiogenesis,24 therefore we believe that development of
apelin/APJ inhibitors might represent a new therapeutic strategy
to prevent pathological neovascularization in ROP. Tnnt2 encodes
a troponin T type 2, which might control excessive angiogenesis in
hypoxic conditions.25 Pcolce gene encodes procollagen C-
endopeptidase enhancer protein that is required for endothelial
cell lumen formation.26 Cebpd gene encodes a transcription factor
CCAAT/enhancer-binding protein D, associated with immune
response27, as well as angiogenesis.28 C4b encodes complement
C4-B involved in a variety of immune processes. B-cell leukemia/
lymphoma 3 (Bcl3) gene serves as death promoter.29 We
hypothesized that its increased expression on P17 corresponded
to massive apoptosis of damaged retinal cells. Additionally, on
P28, observed induction of genes involved in apoptosis might
result in apoptosis of the endothelial cells, causing the already
formed neo-vessels to regress. This observation was in accordance
with the previously reported studies highlighting the role of
apoptosis of the endothelial cells in pathological vascularization
regression.30 Other genes highly overexpressed on P28 were these
engaged in the inflammatory processes: Glycam1 encodes a
proteoglycan ligand for L-selectin, which in turn exerts an anti-
inflammatory effect by prevention of monocyte extravasation,31
Lyz1 encodes lysozyme, a potent antimicrobial protein. The
basement membrane anchoring filament protein Lad1, encoded
by Lad1 gene, contributes to the epithelial stability.32 Lad1 gene
expression is regulated by both lipopolysaccharide stimulation
and glucocorticoid receptor activation.33 Overexpression of the
genes associated with various aspects of immune response might
indicate a local inflammatory process, which continue in the
damaged retina over time. Moreover, we observed an increased
expression of Fgf2os gene, encoding fibroblast growth factor 2
opposite strand, which was hypothesized to aid in preservation of
the neuroretinal function during ischemic retinopathy.34
Table 4. Top list of downregulated genes in retina and blood based on the fold change in their expression between OIR and control mice at different
time points
Time point Gene symbol Log2FC Corrected p-value Gene name
Retina
P12 Ccm2l −4.15 0.0374 Cerebral cavernous malformations 2 protein-like
Abcc9 −3.93 2.0026E-6 ATP-binding cassette subfamily C member 9
Adcy4 −3.10 0.0095 Adenylate cyclase type 4
Arap3 −2.90 0.0075 Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing
protein 3
Mmrn2 −2.85 0.0230 Multimerin-2
Robo4 −2.82 0.0433 Roundabout homolog 4
Cd34 −2.81 0.0400 Hematopoietic progenitor cell antigen CD34
Adgre5 −2.76 2.6282E-9 Adhesion G-protein-coupled receptor E5
Ptprb −2.69 2.0025E-6 Receptor-type tyrosine-protein phosphatase beta
Ets1 −2.66 0.0400 Protein C-ets-1
P17 Cidea −4.44 0.0043 Cell death activator CIDE-A
Kcne1l −4.17 0.0169 Potassium voltage-gated channel subfamily E regulatory beta
subunit 5
Kcnd2 −3.82 0.0430 Potassium voltage-gated channel subfamily D member 2
Spink13 −3.78 0.0166 Serine protease inhibitor Kazal-type 13
Etnppl −3.69 0.0371 Ethanolamine-phosphate phospho-lyase
Spc25 −3.64 7.0628E-9 Kinetochore protein Spc25
Gabrb1 −3.63 0.0163 Gamma-aminobutyric acid receptor subunit beta-1
Tacr3 −3.33 0.0477 Neuromedin-K receptor
Scn11a −3.31 0.0350 Sodium channel protein type 11 subunit alpha
Gpr101 −3.30 0.0039 Probable G-protein-coupled receptor 101
P28 Fam219aos −2.62 0.0099 Family with sequence similarity 219, member A, opposite strand
Grip1 −1.95 0.0405 Glutamate receptor-interacting protein 1
Crabp1 −1.33 0.0417 Cellular retinoic acid-binding protein 1
Blood
P17 Gm1043 −5.02 0.0481 Predicted gene 1043
Gm29260 −4.21 0.0298 Predicted gene 29260
Tbc1d17 −3.63 0.0481 TBC1 domain family member 17
Nol4 −3.23 0.0146 Nucleolar protein 4
Gm4013 −3.13 0.0304 Predicted gene 4013
Gm3970 −2.82 0.0102 Predicted gene 3970
Ccl20 −2.76 0.0434 C-C motif chemokine 20
Cers4 −2.34 0.0253 Ceramide synthase 4
Nbeal1 −2.08 0.0115 Neurobeachin-like 1
Serpina11 −2.03 0.0282 Serpin A11
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Microarray analysis of the blood mononuclear cells revealed
alterations in gene expression pattern only on P17. Our results
indicated that examination of the PBMC’s genome could not
provide a good early biomarker of OIR, which further confirmed
our findings in the previous human study on ROP.11 Lack of the
altered gene expression on P28 indicated transient nature of the
gene expression changes in the blood MNCs caused by hyperoxia.
Moreover, alterations in gene expression present at retina tissue
may appear in PBMCs with a shift of time, therefore they are not
visible at the studied time points. It is also possible, that the
applied experimental procedure that caused only subtle changes
in gene expression at P12 and P28 in the target tissue (retina) was
not potent enough to trigger changes visible in the blood cells. It
should also be taken into consideration that when performing a
statistical analysis with an amendment to multiple comparisons (in
the presented experiments Bonferroni correction was applied),
small differences in gene expression are overlooked. Finally, it is
worth to mention that many of the observed gene expression
changes may be tissue-specific. Consequently we may assume,
that not all changes in expression present in the retina are
reflected in PBMCs.
The genes with the most decreased expression in the PBMC
included the ones encoding proteins involved in various cellular
mechanisms (Serpina11, Tbc1d17,Cers4), immune response (Ccl20),
as well as genes encoding long non-coding RNA (Gm29260,
Gm4013).
There were two genes that showed significantly reduced
expression with FC <−2.0 both in the retinal and blood cells, on
P17. These were Deptor and Nol1 genes. Deptor gene encodes DEP
Domain-Containing mTOR-Interacting Protein, which is a negative
regulator of mammalian target of rapamycin (mTOR) signaling
pathways. The mTOR-signaling pathways were previously shown
to be profoundly interrelated with several mechanisms crucial for
retinopathy progression, including oxidative stress, inflammation,
hypoxia, angiogenesis, and proliferation/fibrosis,35,36 Therefore,
decreased Deptor gene expression in both blood mononuclear
cells and retina might not only mark encountered oxidative stress,
but also indicate effects of mTOR-signaling pathway overactiva-
tion, including neovascularization.
Nucleolar protein 4 (Nol4) gene might be involved in a process
of determining cell specificity.37 As a tumor suppressor gene
showed tissue-specific distribution,37 it was considered as a
Table 5. Top list of upregulated genes in retina and blood based on their expression fold change between OIR and control mice at different
time points
Time point Gene symbol Log2FC Corrected p-value Gene name
Retina
P12 Mri1 1.29 0.0338 Methylthioribose-1-phosphate isomerase
P17 Esm1 49.02 1.3345E-11 Endothelial cell-specific molecule 1
Edn2 18.60 1.8853E-5 Endothelin-2
Bcl3 16.71 1.4607E-8 B-cell lymphoma 3 protein homolog
Apln 16.05 3.7819E-9 Apelin
C4b 11.10 1.3346E-11 Complement C4-B
Pcolce 10.65 6.6323E-11 Procollagen C-endopeptidase enhancer 1
Cebpd 10.47 1.9108E-8 CCAAT/enhancer-binding protein delta
Adm 9.68 7.5001E-11 Adrenomedullin
Tnnt2 8.46 3.2014E-8 Troponin T, cardiac muscle
Gfap 8.06 7.0122E-6 Glial fibrillary acidic protein
P28 Bcl3 4.62 1.2942E-4 B-cell lymphoma 3 protein homolog
C4b 4.17 2.9285E-7 Complement C4-B
Lad1 3.92 0.0023 Ladinin-1
Apln 3.92 0.0012 Apelin
Pcolce 3.64 2.0317E-4 Procollagen C-endopeptidase enhancer 1
Fgf2os 3.22 0.0091 Uncharacterized protein
Tnnt2 2.86 2.8065E-5 Troponin T, cardiac muscle
Cebpd 2.77 6.8232E-4 CCAAT/enhancer-binding protein delta
Lyz1 2.64 0.0099 Lysozyme C-1
Glycam1 2.61 0.0187 Glycosylation-dependent cell adhesion molecule 1
Blood
P17 Taf4 3.11 0.0403 Transcription initiation factor TFIID
Sec22a 2.96 0.0195 Vesicle-trafficking protein SEC22a
Trmt1l 2.91 0.0195 tRNA methyltransferase 1 -like protein
ND2 2.50 0.0070 NADH-ubiquinone oxidoreductase chain 2
Rrp1b 2.32 0.0067 Ribosomal RNA processing protein 1 homolog B
Trp53 2.25 6.9234E-4 Cellular tumor antigen p53
Fam20b 2.23 0.0481 Glycosaminoglycan xylosylkinase
Hmg20b 1.98 0.0067 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E
member 1-related
Gbf1 1.66 0.0304 Golgi-specific brefeldin A-resistance factor-1
Mkln1 1.60 0.0354 Muskelin
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potential biomarker of head and neck cancer, as it was highly
hypermethylated in the patients suffering from these
malignancies,38,39 Its role in the OIR would need to be elucidated.
The genes overexpressed on P17 in the blood were different
from these upregulated in the retinas at the same time point, and
mostly they were involved in transcription and its regulation and
double-strand DNA break repair (Aff3, Baz1b,Dlx5, Hmg20b, Lipin2,
Nelfe, Trp53, Zfp426). There was no surprise to find overexpression
of Trp53 gene since that was an indicator of DNA damage caused
by hyperoxia.40
Limitations
Although our experiment included a sufficient number of animals
and the gene expression analysis was validated and confirmed, we
are aware of some study limitations. The model of continuous
hyperoxia exposure for 5 days is more similar to the former cases
of ROP associated with treatment of neonates with very high
oxygen levels. Future studies with a model more closely
mimicking the clinical situation in preterm infants, such as a rat
model of oxygen-induced retinopathy, are required to confirm the
obtained results. Moreover, we measured only the ambient
oxygen concentration within the chambers. We did not check
SpO2 or pO2 in the mice subjected to hyperoxia during the
hyperoxic period (in order to more precisely monitor hyperoxic
exposure). Additionally, we observed transient extrauterine
growth retardation in our OIR mice, which might have affected
their phenotype. However, we did not observe mice weighing <6
g on P17, that according to Connor et al.3 might have profoundly
altered the vascular phenotype. Validation of gene expression
changes was performed only for selected genes. We understand
that we presented gene expression results for the entire retina,
which consisted of a several types of cells. Our study provided a
starting point for further genetic analysis of ROP, in which we
should investigate regulatory mechanisms of gene expression
such as DNA methylation and/or protein synthesis. In addition our
analysis was based predominantly on the molecular studies, we
believe that future experiments should include functional data,
both in vitro and/or in vivo provided in the specific cell types or in
whole retina.
CONCLUSIONS
Our mRNA expression analysis showed that particular OIR stages
in mice were associated with specific changes in the pattern of
gene expression in the retinas and allowed for selection of the
candidate genes that may be the subject of further, more targeted
studies (i.e., proteomics). Moreover, it also revealed, that
transcriptome blood analysis might not be an early biomarker of
OIR development, although the altered expression of Deptor and
Nol4 gene would require further investigation as they might
become blood indicators of retinal neovascularization. Our work
provided new evidence of the critical role of excessive tissue
oxygenation that resulted in gene expression changes during the
course of each stage of retinopathy of prematurity. The altered
gene expression in retinas might present a long-lasting effect of a
prior hyperoxia, the subsequent consequences of which would
have to be determined in the future studies.
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Fig. 4 Validation of microarray study by real-time PCR technique in all analyzed time points. Part 1—gene expression in retina tissue, part 2—
gene expression in blood
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